Page 70 - Evaluation for Norm Ross

J'*2$,
/$,K'&$&%$
($)*+',$
/012
4*=L
MN/',%
O
3#P6
3-.2%6
ˆ&,.00 #0—.,K10',Œ
lIei
† $0
.1,
O,1=2
.&
TB
v~kxz}y
\eB
\h
~DIT
t ATB2‡.M$,
.1,
vz|q}}lIeit
vwyq~}tv~q~}^ADaB]
UaDCeHBGgaAt}
DCCeDaBGgaA

b\_Df€eIDCHAt
vx|vzk|}}
„Cum\I`
-.2%2
/',%
P/,$K*1K

$2IGHBG\CTt
O,1=? r$)1+%*.&
r$%'*0U]DIVDHfDBeTt
IAhAIIAF
b\TBu
CeDat
vwkxxy
,
Dat
vwkz{y
?c. $2(˜(
/,.=,'K
lAFe@Cf
l\‚eB
s_ACFƒG„C
DCF
CABm\IA
C
@CCeDa
lIeiHBGgaAtl\HB\I
b]\GHAtHB\I\h
U\H`ABGCiVGBt
vw}k}}}‚eBu\hu`
B
sBUs]DIGCiC('*0
5,)$Ce
@@C
^ADaB]v{}}lAFv~}FAFeHlIeib\GCTu
vw}}k

5Z$,'00
%',
ˆ2%*K'%$)&1'0'0%L
'&)=-.2%2?
‰Š‹r'%*&=?
‰Š‹
r$%'*vw
ˆ&,.00
—.,K10',Œ
‰Š‹

O,r$'&/,#00
.1,
O,1=2
.&
#&4$O,1vzk~w}{q~
\eB
\h
~T
TBDI
lAFeUaDC
l\h\I
E\s
‰Š‹
'-.X'Œ-.*&‰Š‹@CCeDa
lIeiHBGgaAt
vx~l\HB\I
b]\GHAlIei
†ATB2‡.M$,
.1,
b
$-.2%2
#&-.2%20U]DIVDHfDBeTt
IAhAIIAF
b\TBu
CeDat
vwkxx{
,
Dat
vwk‘‘w
?c./',%
P/,$K*1K
/‰ŠlI^ADaB]lAFlIei
b\_\GCTu
vw}}k
{
ˆ2%*K'%$)&1'0
O,1=?
‰Š‹(.&%L0Œ,$K*1K?‹q}}eit
v|q}tvxyq‘}^ADaB]
UaDCeHBGgaAt
v}
Df€eIDCHAt
vw‚es_ACFƒG„CuCA
#$%&'
($)*+',$
-.&&$+%
/012
34(56
347879:;8<:;6=$=2%,*+%*.&2
‰Š‹,=,'K2?t $2IGHBG\CTt
O,1=? r$)1+%*.&
5,='&*>'%*.&?
@ABCD
EAFGHDIAO$)1+%*0$2&)
O,1=
‰Š‹
N21,'&+$?4$'0%LP$&$Ž*%2?
‰Š‹O,1=
-.Z$,'1)
5%L$.tHB\ITTBAI’GHATB
\h
U\H`ABGCiVGBt
vzk|}}Bm\I`

$2(˜(
/,.=,'K
@@C
sBUs]DIGCiC('*0
5,)$Ce
ˆ2%*K'%$)5Z$,'00
%',
ˆ2%*K'%$)&1'0
O,1=?
‰Š‹/‰Š 4$'0%L
'&)=-.2%2?
‰Š‹r'%*&=?
‰Š‹
O,
opBID
^Aa_
hI\V
EAFGHDIA
_DfGCi
f\eI
FIei
H\TBTq

M*%L.1%
O,1=
-.Z$,'=$
($)*+',$
4$'0%L
/0'&2
lAFeUaDC
—.,K10',Œ
‰Š‹

O,1#&&1'01vwwk}}“]GT
_aDC
i\Bˆ&,.00 #00
.1,
O,1=2
.&
@CCeDa
lIeiHBGgaAt
v}l\HB\I
b]\GHl\h\I
E\s‚e
L*=L,TB
O$‰Š‹
'-.X'Œ-.*&‰Š‹ /,AlIei
†ATB ($)*+',$”2$2%'%*&=
•~DIT–
c.-.2%2
lIei
b
r$%'*vwyq}}eitvw}zq}DaB]t^ADaB]
UaDCb\_\GCTu
v‘}k
{{
#&-.2%20U]DIVDHfDBeTt
Bu\huCABm\I`
‘kw‘‘
,
Dat
vkwz|
v{~q‘}lAFeHBGgaAt
v}
Df€eIDCHAt
v}s_ACFƒG„CuCA
5,='&*>'%*.&?
S(.&%L0Œ,$K*1K?‹ r$'&)
5%L$.tHB\ITTBAI’GHATB
\h
U\H`ABGCiVGBt
vyk~}}Bm\I`
‡.M$,
.1,.
34Q9R;:;;Q:;6
DGTAI
UAIVDCACBA)1+%*0$2&)
O,1=
‰Š‹
N21,'&+$?4$'0%LP$&$Ž*%2?
‰Š‹O,1=
-.Z$,'=$=2%,*+%*.&2
‰Š‹,=,'K2?t $2IGHBG\CTt
O,1=?=,'K
sB‚e@CCeDat
v*0
5,)$Ce $2(˜(
/,
('@C
lI^A/',%
P/,$K*1K)1+%*.&
?c.r$
5Z$,'00
%',
ˆ2%*K'%$)&1'0'0%L
'&)=-.2%2?
‰Š‹r'%*&=?
‰Š‹
lAFelAFlIei
b\_\GCTu
vw}}k
{
#&4$O,1v|k|}UaDC
B\\
CAmIAFˆ&,.00
‰ ‰Š‹

O,r$'&/,#00
.1,
O,1=2
.&
—.,K10',Œ
B\
gAVADTe
UaDC
l\h\I
E\s
r$%'*v^A
O$)1+%*Š‹
'-.X'Œ-.*&‰Š‹@CCeDa
lIeiHBGgaAt
v}l\HB\I
b]\GHAlIei
† $2‡.M$,
.1,
b -.2%2
/‰Š~DaB]^ADaB]
UaDCeHBGgaAt
v}
Df€eIDCHAt
v}{‚es_ACFƒG„CuCA
5,='&*>'%*.&?
[\]CT
^\_`GCT
^ADaB]bDIA0$2&)
O,1=
‰Š‹
N21,'&+$?4$'0%LP$&$Ž*%2?
‰Š‹O,1=
-.Z$,'=1)
5%L$.tHB\ITTBAI’GHATB
\h
U\H`ABGCiVGBt
vzk|}}Bm\I`

$2(˜(
/,.
#&-.2%20U]DIVDHfDBeTt
BDCFDIF
b\TBu
CeDat
v{kxzy
,
Dat
v{kxy~
?c.r$
ˆ2%*K'%$)&1'0
O,1=?
‰Š‹(.&%L0Œ,$K*1K?‹q}}lIeit
v~q}}tv}q}}/',%
P/,$K*1K)1+%*.&
W.L&2
4.XY*&2
#)Z'&%'=$
(O
34(56
349QQR:;;9:;6$=2%,*+%*.&2
‰Š‹,=,'K2?tc.ATBIGHBG\CTt
O,1=?=,'K
c.%$2?d\eI
H\TBT
VDf
gA
FGhhAIACB
FA_ACFGCi
\C
f\eI
UDIB
j
_IAVGeVk
DCf
UDIB
l
_ACDaBf
B]DB
VDf
D__afk
DCF
m]AB]AI
f\e
neDaGhf
h\I
@@C
sBss]DIGCiC('*0
5,)$Ce

!"

There are four
Advantage plans that
do not include Rx drug
coverage. If you
enrolled in one of these
plans, you would also
need to enroll in a Part
D stand-alone drug
plan.